10-Q 1 gco-20240803.htm 10-Q 10-Q
false--02-01Q200000184982025http://fasb.org/us-gaap/2024#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherAccruedLiabilitiesCurrent0000018498us-gaap:OperatingSegmentsMember2023-01-292023-07-290000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-292023-04-290000018498us-gaap:TrademarksMember2024-02-030000018498us-gaap:SalesRevenueNetMembersrt:NorthAmericaMemberus-gaap:GeographicConcentrationRiskMember2024-02-042024-08-030000018498gco:WholesaleCostsOfDistributionMember2023-04-302023-07-290000018498gco:GenescoBrandsSegmentMemberus-gaap:OperatingSegmentsMember2024-08-0300000184982024-05-040000018498us-gaap:EmployeeSeveranceMember2024-02-042024-08-030000018498gco:JourneysGroupSegmentMemberus-gaap:IntersegmentEliminationMember2023-01-292023-07-290000018498gco:JourneysGroupSegmentMember2024-05-052024-08-030000018498us-gaap:TreasuryStockCommonMember2023-01-280000018498us-gaap:CorporateNonSegmentMember2024-08-030000018498us-gaap:IntersegmentEliminationMembergco:JohnstonAndMurphyGroupSegmentMember2024-05-052024-08-030000018498gco:JohnstonAndMurphyGroupSegmentMember2023-04-302023-07-290000018498us-gaap:SalesRevenueNetMembersrt:NorthAmericaMemberus-gaap:GeographicConcentrationRiskMember2024-05-052024-08-030000018498us-gaap:IntersegmentEliminationMembergco:JohnstonAndMurphyGroupSegmentMember2023-04-302023-07-290000018498us-gaap:IntersegmentEliminationMember2023-01-292023-07-290000018498us-gaap:RevolvingCreditFacilityMember2024-08-030000018498us-gaap:SalesRevenueNetMembersrt:NorthAmericaMemberus-gaap:GeographicConcentrationRiskMember2023-01-292023-07-290000018498country:CA2024-08-030000018498gco:SchuhGroupSegmentMemberus-gaap:IntersegmentEliminationMember2024-02-042024-08-030000018498gco:GenescoBrandsSegmentMemberus-gaap:OperatingSegmentsMember2023-04-302023-07-290000018498us-gaap:SalesRevenueNetMembercountry:GBus-gaap:GeographicConcentrationRiskMember2024-02-042024-08-030000018498gco:GenescoBrandsSegmentMemberus-gaap:OperatingSegmentsMember2023-07-290000018498gco:GenescoBrandsSegmentMember2023-04-302023-07-290000018498us-gaap:CorporateNonSegmentMember2023-07-290000018498gco:JourneysGroupSegmentMembergco:RetailStoreAssetImpairmentsMember2023-01-292023-07-290000018498us-gaap:OperatingSegmentsMembergco:JohnstonAndMurphyGroupSegmentMember2023-04-302023-07-290000018498gco:GenescoBrandsSegmentMember2023-01-292023-07-290000018498gco:JourneysGroupSegmentMembergco:RetailStoreAssetImpairmentsMember2024-02-042024-08-030000018498us-gaap:CommonStockMember2024-05-052024-08-030000018498us-gaap:SubsequentEventMember2024-08-042024-09-110000018498us-gaap:OperatingSegmentsMembergco:JourneysGroupSegmentMember2024-05-052024-08-030000018498us-gaap:CommonStockMember2023-01-292023-04-290000018498gco:GenescoBrandsSegmentMemberus-gaap:IntersegmentEliminationMember2023-01-292023-07-290000018498us-gaap:RetainedEarningsMember2023-01-292023-04-290000018498us-gaap:RetainedEarningsMember2024-05-040000018498gco:SchuhGroupSegmentMemberus-gaap:OperatingSegmentsMember2024-08-030000018498us-gaap:AdditionalPaidInCapitalMember2024-08-030000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-280000018498us-gaap:PreferredStockMember2023-07-290000018498us-gaap:OperatingSegmentsMember2024-02-042024-08-030000018498us-gaap:OperatingSegmentsMembergco:JohnstonAndMurphyGroupSegmentMember2024-02-042024-08-030000018498us-gaap:OperatingSegmentsMember2023-04-302023-07-290000018498us-gaap:PreferredStockMember2024-02-030000018498us-gaap:PreferredStockMember2023-01-292023-04-290000018498gco:JourneysGroupSegmentMemberus-gaap:OperatingSegmentsMember2023-07-290000018498us-gaap:RetainedEarningsMember2023-04-2900000184982023-01-292023-07-290000018498country:GB2024-08-030000018498us-gaap:CommonStockMember2023-01-280000018498us-gaap:RetainedEarningsMember2024-02-030000018498us-gaap:OperatingSegmentsMembergco:JourneysGroupSegmentMember2023-01-292023-07-290000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-05-052024-08-030000018498us-gaap:SalesRevenueNetMembercountry:GBus-gaap:GeographicConcentrationRiskMember2023-04-302023-07-2900000184982024-02-042024-05-040000018498us-gaap:OperatingSegmentsMembergco:JohnstonAndMurphyGroupSegmentMember2023-07-290000018498gco:RetailOccupancyCostsMember2023-01-292023-07-2900000184982023-01-292023-04-290000018498us-gaap:IntersegmentEliminationMembergco:JourneysGroupSegmentMember2024-05-052024-08-030000018498us-gaap:AdditionalPaidInCapitalMember2024-05-052024-08-030000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-290000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-302023-07-290000018498us-gaap:CorporateNonSegmentMember2024-05-052024-08-030000018498us-gaap:IntersegmentEliminationMembergco:JohnstonAndMurphyGroupSegmentMember2023-01-292023-07-290000018498gco:GenescoBrandsSegmentMemberus-gaap:IntersegmentEliminationMember2024-05-052024-08-030000018498us-gaap:TreasuryStockCommonMember2024-02-030000018498us-gaap:RetainedEarningsMember2024-05-052024-08-030000018498gco:JohnstonAndMurphyGroupSegmentMember2024-02-042024-08-030000018498us-gaap:TreasuryStockCommonMember2024-05-040000018498us-gaap:IntersegmentEliminationMembergco:JohnstonAndMurphyGroupSegmentMember2024-02-042024-08-030000018498us-gaap:PreferredStockMember2024-02-042024-05-0400000184982024-02-030000018498us-gaap:OperatingSegmentsMember2024-05-052024-08-030000018498gco:GenescoBrandsSegmentMemberus-gaap:IntersegmentEliminationMember2024-02-042024-08-030000018498gco:WholesaleCostsOfDistributionMember2024-05-052024-08-030000018498gco:RetailOccupancyCostsMember2024-05-052024-08-030000018498gco:JourneysGroupSegmentMember2024-02-042024-08-0300000184982023-07-290000018498us-gaap:AdditionalPaidInCapitalMember2023-01-280000018498gco:SchuhGroupSegmentMemberus-gaap:OperatingSegmentsMember2024-05-052024-08-030000018498country:CA2023-07-290000018498gco:RetailOccupancyCostsMember2024-02-042024-08-030000018498us-gaap:AdditionalPaidInCapitalMember2023-04-302023-07-290000018498us-gaap:CommonStockMember2023-04-302023-07-290000018498gco:RetailOccupancyCostsMember2023-04-302023-07-290000018498us-gaap:FairValueInputsLevel3Member2024-08-030000018498gco:JourneysGroupSegmentMemberus-gaap:OperatingSegmentsMember2024-02-042024-08-0300000184982024-08-030000018498gco:SchuhGroupSegmentMember2024-02-042024-08-0300000184982024-08-300000018498gco:SchuhGroupSegmentMemberus-gaap:OperatingSegmentsMember2023-01-292023-07-290000018498us-gaap:RetainedEarningsMember2023-04-302023-07-290000018498us-gaap:CorporateNonSegmentMember2023-04-302023-07-290000018498us-gaap:SalesRevenueNetMembercountry:GBus-gaap:GeographicConcentrationRiskMember2023-01-292023-07-290000018498us-gaap:AdditionalPaidInCapitalMember2023-07-290000018498us-gaap:IntersegmentEliminationMember2024-02-042024-08-030000018498gco:USRevolverBorrowingsMember2024-08-030000018498us-gaap:CommonStockMember2024-05-0400000184982024-05-052024-08-030000018498us-gaap:TreasuryStockCommonMember2023-04-290000018498us-gaap:IntersegmentEliminationMembergco:JourneysGroupSegmentMember2024-02-042024-08-030000018498gco:JourneysGroupSegmentMembergco:RetailStoreAssetImpairmentsMember2023-04-302023-07-290000018498us-gaap:OperatingSegmentsMembergco:JohnstonAndMurphyGroupSegmentMember2024-08-030000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-02-042024-05-0400000184982023-04-302023-07-290000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-05-040000018498us-gaap:OtherIntangibleAssetsMember2024-08-030000018498us-gaap:AdditionalPaidInCapitalMember2024-02-030000018498us-gaap:IntersegmentEliminationMembergco:JourneysGroupSegmentMember2023-04-302023-07-290000018498us-gaap:RetainedEarningsMember2024-08-030000018498us-gaap:TrademarksMember2024-08-030000018498us-gaap:RetainedEarningsMember2023-01-280000018498us-gaap:CommonStockMember2024-02-030000018498gco:WholesaleCostsOfDistributionMember2023-01-292023-07-290000018498gco:JourneysGroupSegmentMember2023-04-302023-07-290000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-290000018498us-gaap:OperatingSegmentsMembergco:JourneysGroupSegmentMember2024-08-030000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-02-0300000184982023-01-280000018498gco:JohnstonAndMurphyGroupSegmentMember2023-01-292023-07-290000018498us-gaap:AdditionalPaidInCapitalMember2024-05-040000018498gco:GenescoBrandsSegmentMember2024-02-042024-08-030000018498us-gaap:RevolvingCreditFacilityMembergco:GenescoCanadaUlcMember2024-08-030000018498us-gaap:CustomerListsMember2024-02-030000018498us-gaap:SalesRevenueNetMemberus-gaap:GeographicConcentrationRiskMembersrt:NorthAmericaMember2023-04-302023-07-290000018498country:GB2023-07-290000018498us-gaap:RevolvingCreditFacilityMembergco:USRevolverBorrowingsMember2024-08-030000018498us-gaap:PreferredStockMember2024-05-040000018498srt:MaximumMember2024-08-030000018498us-gaap:OperatingSegmentsMembergco:JohnstonAndMurphyGroupSegmentMember2024-05-052024-08-030000018498gco:SchuhGroupSegmentMemberus-gaap:IntersegmentEliminationMember2023-01-292023-07-290000018498gco:GenescoBrandsSegmentMemberus-gaap:OperatingSegmentsMember2024-05-052024-08-030000018498us-gaap:IntersegmentEliminationMember2023-04-302023-07-290000018498gco:SchuhGroupSegmentMemberus-gaap:OperatingSegmentsMember2023-07-290000018498us-gaap:SalesRevenueNetMembercountry:GBus-gaap:GeographicConcentrationRiskMember2024-05-052024-08-030000018498gco:JourneysGroupSegmentMembergco:RetailStoreAssetImpairmentsMember2024-05-052024-08-030000018498gco:JourneysGroupSegmentMemberus-gaap:OperatingSegmentsMember2023-04-302023-07-290000018498gco:GenescoBrandsSegmentMemberus-gaap:IntersegmentEliminationMember2023-04-302023-07-290000018498us-gaap:CommonStockMember2023-07-290000018498gco:SchuhGroupSegmentMemberus-gaap:IntersegmentEliminationMember2024-05-052024-08-030000018498us-gaap:CorporateNonSegmentMember2024-02-042024-08-030000018498us-gaap:CorporateNonSegmentMember2023-01-292023-07-2900000184982023-04-290000018498gco:SchuhGroupSegmentMember2024-05-052024-08-030000018498us-gaap:AdditionalPaidInCapitalMember2024-02-042024-05-040000018498us-gaap:FairValueInputsLevel1Member2024-08-030000018498us-gaap:CustomerListsMember2024-08-030000018498us-gaap:PreferredStockMember2024-08-030000018498gco:GenescoBrandsSegmentMember2024-05-052024-08-030000018498us-gaap:TreasuryStockCommonMember2023-07-290000018498us-gaap:CommonStockMember2023-04-290000018498us-gaap:CommonStockMember2024-08-030000018498gco:WholesaleCostsOfDistributionMember2024-02-042024-08-030000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-08-030000018498gco:JourneysGroupSegmentMember2023-01-292023-07-290000018498us-gaap:AdditionalPaidInCapitalMember2023-04-290000018498us-gaap:PreferredStockMember2023-04-290000018498gco:SchuhGroupSegmentMember2023-04-302023-07-290000018498gco:GenescoBrandsSegmentMemberus-gaap:OperatingSegmentsMember2024-02-042024-08-030000018498us-gaap:RetainedEarningsMember2024-02-042024-05-040000018498gco:JohnstonAndMurphyGroupSegmentMember2024-05-052024-08-030000018498us-gaap:EmployeeSeveranceMember2024-05-052024-08-030000018498gco:USRevolverBorrowingsMember2024-02-030000018498us-gaap:IntersegmentEliminationMember2024-05-052024-08-030000018498us-gaap:PreferredStockMember2023-01-280000018498us-gaap:OtherIntangibleAssetsMember2024-02-030000018498us-gaap:TreasuryStockCommonMember2024-08-030000018498gco:SchuhGroupSegmentMemberus-gaap:IntersegmentEliminationMember2023-04-302023-07-290000018498us-gaap:OperatingSegmentsMembergco:JohnstonAndMurphyGroupSegmentMember2023-01-292023-07-290000018498gco:GenescoBrandsSegmentMemberus-gaap:OperatingSegmentsMember2023-01-292023-07-290000018498gco:SchuhGroupSegmentMemberus-gaap:OperatingSegmentsMember2023-04-302023-07-290000018498us-gaap:AdditionalPaidInCapitalMember2023-01-292023-04-290000018498gco:SchuhGroupSegmentMember2023-01-292023-07-2900000184982024-02-042024-08-030000018498gco:SchuhGroupSegmentMemberus-gaap:OperatingSegmentsMember2024-02-042024-08-030000018498us-gaap:CommonStockMember2024-02-042024-05-040000018498us-gaap:RetainedEarningsMember2023-07-29iso4217:USDxbrli:sharesxbrli:purexbrli:sharesiso4217:CADgco:Storegco:Segmentiso4217:USD

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended August 3, 2024

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to

Commission File No. 1-3083

Genesco Inc.

(Exact name of registrant as specified in its charter)

Tennessee

62-0211340

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

 

 

 

 

535 Marriott Drive

 

37214

Nashville,

Tennessee

 

(Zip Code)

(Address of principal executive offices)

 

 

 

Registrant's telephone number, including area code: (615) 367-7000

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $1.00 par value

GCO

New York Stock Exchange

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such report), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer; an accelerated filer; a non-accelerated filer; a smaller reporting company; or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes No

As of August 30, 2024, there were 11,221,864 shares of the registrant's common stock outstanding.

 


 

INDEX

 

Part I. Financial Information

Item 1. Financial Statements:

Condensed Consolidated Balance Sheets - August 3, 2024, February 3, 2024 and July 29, 2023

4

Condensed Consolidated Statements of Operations - Three and Six Months ended August 3, 2024 and July 29, 2023

5

Condensed Consolidated Statements of Comprehensive Loss - Three and Six Months ended August 3, 2024 and July 29, 2023

6

Condensed Consolidated Statements of Cash Flows - Three and Six Months ended August 3, 2024 and July 29, 2023

7

Condensed Consolidated Statements of Equity - Three and Six Months ended August 3, 2024 and July 29, 2023

8

Notes to Condensed Consolidated Financial Statements

9

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

15

Item 3. Quantitative and Qualitative Disclosures about Market Risk

23

Item 4. Controls and Procedures

23

Part II. Other Information

24

Item 1. Legal Proceedings

24

Item 1A. Risk Factors

24

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

24

Item 5. Other Information

24

Item 6. Exhibits

25

Signature

26

 

 

 

2


 

cautionary notice regarding forward-looking statements

Statements in this Quarterly Report on Form 10-Q include certain forward-looking statements, which include statements regarding our intent, belief or expectations and all statements other than those made solely with respect to historical fact. Actual results could differ materially from those reflected by the forward-looking statements in this Quarterly Report on Form 10-Q and a number of factors may adversely affect the forward-looking statements and our future results, liquidity, capital resources or prospects. These include, but are not limited to, adjustments to projections reflected in forward-looking statements, including those resulting from weakness in store and shopping mall traffic, restrictions on operations imposed by government entities and/or landlords, changes in public safety and health requirements and limitations on our ability to adequately staff and operate stores. Differences from expectations could also result from our ability to obtain from suppliers products that are in-demand on a timely basis and effectively manage disruptions in product supply or distribution, including disruptions as a result of pandemics or geopolitical events, including shipping disruptions in the Red Sea; the level of consumer spending on our merchandise and interest in our brands and in general; the level and timing of promotional activity necessary to maintain inventories at appropriate levels; our ability to pass on price increases to our customers; the timing and amount of any share repurchases by us; the imposition of tariffs on products imported by us or our vendors as well as the ability and costs to move production of products in response to tariffs; unfavorable trends in fuel costs, foreign exchange rates, foreign labor and material costs; a disruption in shipping or increase in cost of our imported products, and other factors affecting the cost of products; our dependence on third-party vendors and licensors for the products we sell; our ability to renew our license agreements; impacts of the Russia-Ukraine war, and other sources of market weakness in the U.K. and the Republic of Ireland; the effectiveness of our omni-channel initiatives; costs associated with changes in minimum wage and overtime requirements; wage pressure in the U.S. and the U.K.; labor shortages; the effects of inflation; the evolving regulatory landscape related to our use of social media; the establishment and protection of our intellectual property; weakness in the consumer economy and retail industry; competition and fashion trends in our markets, including trends with respect to the popularity of casual and dress footwear; any failure to increase sales at our existing stores, given our high fixed expense cost structure, and in our e-commerce businesses; risks related to the potential for terrorist events; store closures and effects on the business as a result of civil disturbances; changes in buying patterns by significant wholesale customers; changes in consumer preferences; our ability to continue to complete and integrate acquisitions; our ability to expand our business and diversify our product base; impairment of goodwill in connection with acquisitions; payment related risks that could increase our operating cost, expose us to fraud or theft, subject us to potential liability and disrupt our business; retained liabilities associated with divestitures of businesses including potential liabilities under leases as the prior tenant or as a guarantor of certain leases; and changes in the timing of holidays or in the onset of seasonal weather affecting period-to-period sales comparisons. Additional factors that could cause differences from expectations include the ability to secure allocations to refine product assortments to address consumer demand; the ability to renew leases in existing stores and control or lower occupancy costs, to open or close stores in the number and on the planned schedule, and to conduct required remodeling or refurbishment on schedule and at expected expense levels; our ability to realize anticipated cost savings, including rent savings; our ability to make our occupancy costs more variable, realize any anticipated tax benefits in both the amount and timeframe anticipated, and achieve expected digital gains and gain market share; deterioration in the performance of individual businesses or of our market value relative to our book value, resulting in impairments of fixed assets, operating lease right of use assets or intangible assets or other adverse financial consequences and the timing and amount of such impairments or other consequences; unexpected changes to the market for our shares or for the retail sector in general; our ability to meet our sustainability, stewardship, emission and diversity, equity and inclusion related ESG projections, goals and commitments; costs and reputational harm as a result of disruptions in our business or information technology systems either by security breaches and incidents or by potential problems associated with the implementation of new or upgraded systems, and the cost and outcome of litigation, investigations, disputes and environmental matters that involve us. For a full discussion of risk factors, see Item 1A, "Risk Factors".

Readers are cautioned not to place undue reliance on forward-looking statements as such statements speak only as of the date they were made and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The most important factors which could cause our actual results to differ from our forward-looking statements are set forth in our description of risk factors in Item 1A contained in our Annual Report on Form 10-K for the fiscal year ended February 3, 2024 which should be read in conjunction with the forward-looking statements in this Quarterly Report on Form 10-Q. Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update any forward-looking statement.

The events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. As a result, our actual results may differ materially from the results contemplated by these forward-looking statements.

We maintain a website at www.genesco.com where investors and other interested parties may obtain, free of charge, press releases and other information as well as gain access to our periodic filings with the Securities and Exchange Commission (“SEC”). The information contained on this website should not be considered to be a part of this or any other report filed with or furnished to the SEC.

3


 

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements (unaudited)

 

Genesco Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(In thousands, except share amounts)

 

Assets

 

August 3, 2024

 

 

February 3, 2024

 

 

July 29, 2023

 

Current Assets:

 

 

 

 

 

 

 

 

 

Cash

 

$

45,855

 

 

$

35,155

 

 

$

37,416

 

Accounts receivable, net of allowances of $2,409 at August 3, 2024,

 

 

 

 

 

 

 

 

 

   $4,266 at February 3, 2024 and $4,536 at July 29, 2023

 

 

57,497

 

 

 

53,618

 

 

 

50,351

 

Inventories

 

 

450,187

 

 

 

378,967

 

 

 

491,118

 

Prepaids and other current assets

 

 

53,181

 

 

 

39,611

 

 

 

45,983

 

Total current assets

 

 

606,720

 

 

 

507,351

 

 

 

624,868

 

Property and equipment, net

 

 

229,116

 

 

 

240,266

 

 

 

244,090

 

Operating lease right of use assets

 

 

402,715

 

 

 

436,896

 

 

 

476,715

 

Non-current prepaid income taxes

 

 

58,051

 

 

 

56,839

 

 

 

55,028

 

Goodwill

 

 

9,284

 

 

 

9,565

 

 

 

9,717

 

Other intangibles

 

 

27,162

 

 

 

27,250

 

 

 

27,952

 

Deferred income taxes

 

 

25,287

 

 

 

26,230

 

 

 

30,623

 

Other noncurrent assets

 

 

25,416

 

 

 

25,493

 

 

 

25,766

 

Total Assets

 

 

1,383,751

 

 

 

1,329,890

 

 

 

1,494,759

 

Liabilities and Equity

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

 

Accounts payable

 

 

187,439

 

 

 

114,621

 

 

 

166,504

 

Current portion - operating lease liabilities

 

 

122,527

 

 

 

129,189

 

 

 

137,369

 

Other accrued liabilities

 

 

85,697

 

 

 

75,727

 

 

 

78,707

 

Total current liabilities

 

 

395,663

 

 

 

319,537

 

 

 

382,580

 

Long-term debt

 

 

77,839

 

 

 

34,682

 

 

 

131,544

 

Long-term operating lease liabilities

 

 

329,773

 

 

 

359,073

 

 

 

403,413

 

Other long-term liabilities

 

 

47,854

 

 

 

45,396

 

 

 

44,203

 

Total liabilities

 

 

851,129

 

 

 

758,688

 

 

 

961,740

 

Commitments and contingent liabilities

 

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

 

 

Non-redeemable preferred stock

 

 

812

 

 

 

813

 

 

 

812

 

Common equity:

 

 

 

 

 

 

 

 

 

Common stock, $1 par value:

 

 

 

 

 

 

 

 

 

Authorized: 80,000,000 shares

 

 

 

 

 

 

 

 

 

 Issued common stock

 

 

11,707

 

 

 

11,961

 

 

 

11,996

 

Additional paid-in capital

 

 

325,775

 

 

 

319,143

 

 

 

313,019

 

Retained earnings

 

 

251,351

 

 

 

296,766

 

 

 

263,081

 

Accumulated other comprehensive loss

 

 

(39,166

)

 

 

(39,624

)

 

 

(38,032

)

Treasury shares, at cost (488,464 shares)

 

 

(17,857

)

 

 

(17,857

)

 

 

(17,857

)

Total equity

 

 

532,622

 

 

 

571,202

 

 

 

533,019

 

Total Liabilities and Equity

 

$

1,383,751

 

 

$

1,329,890

 

 

$

1,494,759

 

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

4


 

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(In thousands, except per share amounts)

 

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

August 3, 2024

 

 

July 29, 2023

 

 

August 3, 2024

 

 

July 29, 2023

 

Net sales

 

$

525,188

 

 

$

523,027

 

 

$

982,785

 

 

$

1,006,359

 

Cost of sales

 

 

279,549

 

 

 

273,507

 

 

 

520,865

 

 

 

528,031

 

Gross margin

 

 

245,639

 

 

 

249,520

 

 

 

461,920

 

 

 

478,328

 

Selling and administrative expenses

 

 

255,135

 

 

 

259,520

 

 

 

502,966

 

 

 

511,017

 

Goodwill impairment

 

 

 

 

 

28,453

 

 

 

 

 

 

28,453

 

Asset impairments and other, net

 

 

778

 

 

 

174

 

 

 

1,356

 

 

 

482

 

Operating loss

 

 

(10,274

)

 

 

(38,627

)

 

 

(42,402

)

 

 

(61,624

)

Other components of net periodic benefit cost

 

 

86

 

 

 

148

 

 

 

195

 

 

 

240

 

Interest expense, net

 

 

1,345

 

 

 

2,383

 

 

 

2,235

 

 

 

4,034

 

Loss from continuing operations before income taxes

 

 

(11,705

)

 

 

(41,158

)

 

 

(44,832

)

 

 

(65,898

)

Income tax benefit

 

 

(1,776

)

 

 

(9,526

)

 

 

(10,615

)

 

 

(15,391

)

Loss from continuing operations

 

 

(9,929

)

 

 

(31,632

)

 

 

(34,217

)

 

 

(50,507

)

Loss from discontinued operations, net of tax

 

 

(63

)

 

 

(33

)

 

 

(122

)

 

 

(48

)

Net Loss

 

$

(9,992

)

 

$

(31,665

)

 

$

(34,339

)

 

$

(50,555

)

 

 

 

 

 

 

 

 

 

 

 

 

Basic loss per common share:

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

(0.91

)

 

$

(2.79

)

 

$

(3.13

)

 

$

(4.36

)

Discontinued operations

 

 

0.00

 

 

 

0.00

 

 

 

(0.01

)

 

 

(0.01

)

Net loss

 

$

(0.91

)

 

$

(2.79

)

 

$

(3.14

)

 

$

(4.37

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted loss per common share:

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

(0.91

)

 

$

(2.79

)

 

$

(3.13

)

 

$

(4.36

)

Discontinued operations

 

 

0.00

 

 

 

0.00

 

 

 

(0.01

)

 

 

(0.01

)

Net loss

 

$

(0.91

)

 

$

(2.79

)

 

$

(3.14

)

 

$

(4.37

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

10,942

 

 

 

11,344

 

 

 

10,936

 

 

 

11,581

 

Diluted

 

 

10,942

 

 

 

11,344

 

 

 

10,936

 

 

 

11,581

 

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

5


 

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Loss

(In thousands)

 

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

August 3, 2024

 

 

July 29, 2023

 

 

August 3, 2024

 

 

July 29, 2023

 

Net loss

 

$

(9,992

)

 

$

(31,665

)

 

$

(34,339

)

 

$

(50,555

)

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

Postretirement liability adjustments, net of tax

 

 

21

 

 

 

62

 

 

 

59

 

 

 

91

 

Foreign currency translation adjustments

 

 

1,372

 

 

 

2,643

 

 

 

399

 

 

 

3,088

 

Total other comprehensive income

 

 

1,393

 

 

 

2,705

 

 

 

458

 

 

 

3,179

 

Comprehensive Loss

 

$

(8,599

)

 

$

(28,960

)

 

$

(33,881

)

 

$

(47,376

)

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

6


 

 

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(In thousands)

 

 

 

Six Months Ended

 

 

 

August 3, 2024

 

 

July 29, 2023

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

Net loss

 

$

(34,339

)

 

$

(50,555

)

Adjustments to reconcile net loss to net cash used in

 

 

 

 

 

 

operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

26,406

 

 

 

23,119

 

Deferred income taxes

 

 

1,535

 

 

 

(1,576

)

Goodwill impairment

 

 

 

 

 

28,453

 

Impairment of long-lived assets

 

 

360

 

 

 

482

 

Share-based compensation expense

 

 

6,760

 

 

 

7,925

 

Other

 

 

204

 

 

 

686

 

Changes in working capital and other assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(3,619

)

 

 

(9,623

)

Inventories

 

 

(70,873

)

 

 

(30,237

)

Prepaids and other current assets

 

 

(13,492

)

 

 

(19,901

)

Accounts payable

 

 

73,636

 

 

 

23,394

 

Other accrued liabilities

 

 

9,032

 

 

 

(1,076

)

Other assets and liabilities

 

 

(1,639

)

 

 

3,774

 

Net cash used in operating activities

 

 

(6,029

)

 

 

(25,135

)

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

Capital expenditures

 

 

(14,274

)

 

 

(35,298

)

Proceeds from asset sales

 

 

 

 

 

87

 

Net cash used in investing activities

 

 

(14,274

)

 

 

(35,211

)

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

Borrowings under revolving credit facility

 

 

197,610

 

 

 

244,452

 

Payments on revolving credit facility

 

 

(154,376

)

 

 

(158,405

)

Shares repurchased related to share repurchase plan

 

 

(9,349

)

 

 

(32,027

)

Shares repurchased related to taxes for share-based awards

 

 

(2,074

)

 

 

(2,205

)

Change in overdraft balances

 

 

(889

)

 

 

(2,707

)

Net cash provided by financing activities

 

 

30,922

 

 

 

49,108

 

Effect of foreign exchange rate fluctuations on cash

 

 

81

 

 

 

664

 

Net increase (decrease) in cash

 

 

10,700

 

 

 

(10,574

)

Cash at beginning of period

 

 

35,155

 

 

 

47,990

 

Cash at end of period

 

$

45,855

 

 

$

37,416

 

Supplemental information:

 

 

 

 

 

 

Interest paid

 

$

1,995

 

 

$

3,380

 

Income taxes paid

 

 

1,581

 

 

 

3,813

 

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

7


 

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Equity

(In thousands)

 

 

Non-
Redeemable
Preferred
Stock

 

Common
Stock

 

Additional
Paid-In
Capital

 

Retained
Earnings

 

Accumulated
Other
Comprehensive
Loss

 

Treasury
Shares

 

Total
Equity

 

Balance January 28, 2023

$

815

 

$

13,089

 

$

305,260

 

$

346,870

 

$

(41,211

)

$

(17,857

)

$

606,966

 

Net loss

 

 

 

 

 

 

 

(18,890

)

 

 

 

 

 

(18,890

)

Other comprehensive income

 

 

 

 

 

 

 

 

 

474

 

 

 

 

474

 

Share-based compensation expense

 

 

 

 

 

3,772

 

 

 

 

 

 

 

 

3,772

 

Restricted stock issuance

 

 

 

234

 

 

(234

)

 

 

 

 

 

 

 

 

Restricted shares withheld for taxes

 

 

 

(13

)

 

13

 

 

(449

)

 

 

 

 

 

(449

)

Shares repurchased

 

 

 

(255

)

 

 

 

(8,915

)

 

 

 

 

 

(9,170

)

Excise taxes related to repurchases of common stock

 

 

 

 

 

 

 

(78

)

 

 

 

 

 

(78

)

Other

 

(3

)

 

(3

)

 

6

 

 

 

 

 

 

 

 

 

 Balance April 29, 2023

 

812

 

 

13,052

 

 

308,817

 

 

318,538

 

 

(40,737

)

 

(17,857

)

 

582,625

 

Net loss

 

 

 

 

 

 

 

(31,665

)

 

 

 

 

 

(31,665

)

Other comprehensive income

 

 

 

 

 

 

 

 

 

2,705

 

 

 

 

2,705

 

Share-based compensation expense

 

 

 

 

 

4,153

 

 

 

 

 

 

 

 

4,153

 

Restricted stock issuance

 

 

 

40

 

 

(40

)

 

 

 

 

 

 

 

 

Shares repurchased

 

 

 

(1,006

)

 

 

 

(21,851

)

 

 

 

 

 

(22,857

)

Excise taxes related to repurchases of common stock

 

 

 

 

 

 

 

(185

)

 

 

 

 

 

(185

)

Restricted shares withheld for taxes

 

 

 

(72

)

 

72

 

 

(1,756

)

 

 

 

 

 

(1,756

)

Other

 

 

 

(18

)

 

17

 

 

 

 

 

 

 

 

(1

)

Balance July 29, 2023

$

812

 

$

11,996

 

$

313,019

 

$

263,081

 

$

(38,032

)

$

(17,857

)

$

533,019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-
Redeemable
Preferred
Stock

 

Common
Stock

 

Additional
Paid-In
Capital

 

Retained
Earnings

 

Accumulated
Other
Comprehensive
Loss

 

Treasury
Shares

 

Total
Equity

 

Balance February 3, 2024

$

813

 

$

11,961

 

$

319,143

 

$

296,766

 

$

(39,624

)

$

(17,857

)

$

571,202

 

Net loss

 

 

 

 

 

 

 

(24,347

)

 

 

 

 

 

(24,347

)

Other comprehensive loss

 

 

 

 

 

 

 

 

 

(935

)

 

 

 

(935

)

Share-based compensation expense

 

 

 

 

 

3,307

 

 

 

 

 

 

 

 

3,307

 

Restricted stock issuance

 

 

 

198

 

 

(198

)

 

 

 

 

 

 

 

 

Restricted shares withheld for taxes

 

 

 

(29

)

 

29

 

 

(773

)

 

 

 

 

 

(773

)

Other

 

(1

)

 

(8

)

 

7

 

 

1

 

 

 

 

 

 

(1

)

Balance May 4, 2024

 

812

 

 

12,122

 

 

322,288

 

 

271,647

 

 

(40,559

)

 

(17,857

)

 

548,453

 

Net loss

 

 

 

 

 

 

 

(9,992

)

 

 

 

 

 

(9,992

)

Other comprehensive income

 

 

 

 

 

 

 

 

 

1,393

 

 

 

 

1,393

 

Share-based compensation expense

 

 

 

 

 

3,453

 

 

 

 

 

 

 

 

3,453

 

Restricted stock issuance

 

 

 

37

 

 

(37

)

 

 

 

 

 

 

 

 

Shares repurchased

 

 

 

(382

)

 

 

 

(8,967

)

 

 

 

 

 

(9,349

)

Excise taxes related to repurchases of common stock

 

 

 

 

 

 

 

(35

)

 

 

 

 

 

(35

)

Restricted shares withheld for taxes

 

 

 

(49

)

 

49

 

 

(1,301

)

 

 

 

 

 

(1,301

)

Other

 

 

 

(21

)

 

22

 

 

(1

)

 

 

 

 

 

 

Balance August 3, 2024

$

812

 

$

11,707

 

$

325,775

 

$

251,351

 

$

(39,166

)

$

(17,857

)

$

532,622

 

 

 

 

 

 

 

 

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

8


Genesco Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

 

 

Note 1

Summary of Significant Accounting Policies

Basis of Presentation

These Condensed Consolidated Financial Statements should be read in conjunction with our Consolidated Financial Statements and Notes for Fiscal 2024, which are contained in our Annual Report on Form 10-K as filed with the SEC on March 27, 2024. The Condensed Consolidated Financial Statements and Notes contained in this report are unaudited but reflect all adjustments, including normal recurring adjustments, necessary for a fair presentation of the results for the interim periods of the fiscal year ending February 1, 2025 ("Fiscal 2025"), which is a 52-week year, and of the fiscal year ended February 3, 2024 ("Fiscal 2024"), which was a 53-week year. All subsidiaries are consolidated in the Condensed Consolidated Financial Statements. All significant intercompany transactions and accounts have been eliminated. The results of operations for any interim period are not necessarily indicative of results for the full year. The Condensed Consolidated Financial Statements and the related Notes have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and notes required by U.S. Generally Accepted Accounting Principles (“GAAP”) for complete financial statements. The Condensed Consolidated Balance Sheet as of February 3, 2024 has been derived from the audited financial statements at that date.

Nature of Operations

Genesco Inc. and its subsidiaries (collectively the "Company", "Genesco," "we", "our", or "us") business includes the sourcing and design, marketing and distribution of footwear and accessories through retail stores in the U.S., Puerto Rico and Canada primarily under the Journeys®, Journeys Kidz®, Little Burgundy® and Johnston & Murphy® banners and under the Schuh® banner in the United Kingdom (“U.K.”) and the Republic of Ireland (“ROI”); through e-commerce websites including the following: journeys.com, journeyskidz.com, journeys.ca, littleburgundyshoes.com, schuh.co.uk, schuh.ie, schuh.eu, johnstonmurphy.com, johnstonmurphy.ca, nashvilleshoewarehouse.com and dockersshoes.com as well as catalogs. We also source, design, market and distribute footwear and accessories at wholesale, primarily under our Johnston & Murphy brand, the licensed Levi's® brand, the licensed Dockers® brand, the licensed G.H. Bass® brand and other brands that we license for footwear. At August 3, 2024, we operated 1,314 retail stores in the U.S., Puerto Rico, Canada, the U.K. and the ROI.

During the three and six months ended August 3, 2024 and July 29, 2023, we operated four reportable business segments (not including corporate): (i) Journeys Group, comprised of the Journeys, Journeys Kidz and Little Burgundy retail footwear chains and e-commerce operations; (ii) Schuh Group, comprised of the Schuh retail footwear chain and e-commerce operations; (iii) Johnston & Murphy Group, comprised of Johnston & Murphy retail operations, e-commerce operations and wholesale distribution of products under the Johnston & Murphy brand; and (iv) Genesco Brands Group, comprised of the licensed Dockers, Levi's, and G.H. Bass brands, as well as other brands we license for footwear.

Selling and Administrative Expenses

Wholesale costs of distribution are included in selling and administrative expenses on the Condensed Consolidated Statements of Operations in the amount of $2.6 million and $2.5 million for the second quarters of Fiscal 2025 and Fiscal 2024, respectively, and $5.0 million and $6.0 million for the first six months of Fiscal 2025 and Fiscal 2024, respectively.

Retail occupancy costs recorded in selling and administrative expenses were $73.5 million and $76.4 million for the second quarters of Fiscal 2025 and Fiscal 2024, respectively, and $149.0 million and $152.8 million for the first six months of Fiscal 2025 and Fiscal 2024, respectively.

 

Advertising Costs

Advertising costs were $27.7 million and $28.1 million for the second quarters of Fiscal 2025 and Fiscal 2024, respectively, and $51.4 million and $51.7 million for the first six months of Fiscal 2025 and Fiscal 2024, respectively.

Vendor Allowances

Vendor reimbursements of cooperative advertising costs recognized as a reduction of selling and administrative expenses were $2.7 million and $1.9 million for the second quarters of Fiscal 2025 and Fiscal 2024, respectively, and $4.6 million and $6.6 million for the first six months of Fiscal 2025 and Fiscal 2024, respectively. During the first six months of each of Fiscal 2025 and Fiscal 2024, our cooperative advertising reimbursements received were not in excess of the costs incurred.

 

9


Genesco Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

 

 

Note 1

Summary of Significant Accounting Policies, Continued

New Accounting Pronouncements

We continuously monitor and review all current accounting pronouncements and standards from the FASB of U.S. GAAP for applicability to our operations and financial reporting. As of August 3, 2024, there were no other new pronouncements or interpretations, other than those disclosed in the Annual Report on Form 10-K for the fiscal year ended February 3, 2024, that had or were expected to have a significant impact on our financial reporting.

Note 2

Goodwill and Other Intangible Assets

The changes in the carrying amount of goodwill for the Journeys Group segment were as follows:

 

(In thousands)

Total
Goodwill

 

Balance, February 3, 2024

$

9,565

 

Effect of foreign currency exchange rates

 

(281

)

Balance, August 3, 2024

$

9,284

 

Other intangibles by major classes were as follows:

 

 

 

Trademarks

 

Customer Lists

 

 

Other

 

 

Total

 

(In thousands)

 

Aug. 3, 2024

 

 

Feb. 3, 2024

 

Aug. 3, 2024

 

 

Feb. 3, 2024

 

 

Aug. 3, 2024

 

 

Feb. 3, 2024

 

 

Aug. 3, 2024

 

 

Feb. 3, 2024

 

Gross other intangibles

 

$

24,659

 

 

$

24,464

 

$

6,516

 

 

$

6,501

 

 

$

400

 

 

$

400

 

 

$

31,575

 

 

$

31,365

 

Accumulated amortization

 

 

 

 

 

 

 

(4,013

)

 

 

(3,715

)

 

 

(400

)

 

 

(400

)

 

 

(4,413

)

 

 

(4,115

)

Net Other Intangibles

 

$

24,659

 

 

$

24,464

 

$

2,503

 

 

$

2,786

 

 

$

 

 

$

 

 

$

27,162

 

 

$

27,250

 

 

Note 3

Inventories

 

 

(In thousands)

 

August 3, 2024

 

 

February 3, 2024

 

Wholesale finished goods

 

$

71,514

 

 

$

57,678

 

Retail merchandise

 

 

378,673

 

 

 

321,289

 

Total Inventories

 

$

450,187

 

 

$

378,967

 

 

10


Genesco Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

 

 

Note 4

Fair Value

Fair Value of Financial Instruments

The carrying amounts and fair values of our financial instruments at August 3, 2024 and February 3, 2024 are:

 

 

 

 

(In thousands)

August 3, 2024

 

February 3, 2024

 

 

Carrying
Amount

 

Fair
Value

 

Carrying
Amount

 

Fair
Value

 

U.S. Revolver Borrowings

$

77,839

 

$

78,291

 

$

34,682

 

$

34,638

 

Total Long-Term Debt

$

77,839

 

$

78,291

 

$

34,682

 

$

34,638

 

 

Debt fair values were determined using a discounted cash flow analysis based on current market interest rates for similar types of financial instruments and would be classified in Level 2 within the fair value hierarchy. We did not have any debt classified as current portion as of August 3, 2024 or February 3, 2024.

 

As of August 3, 2024, we have $1.1 million of long-lived assets held and used which were measured using Level 3 inputs within the fair value hierarchy. As of August 3, 2024, we have $6.7 million of investments held and used which were measured using Level 1 inputs within the fair value hierarchy.

 

Note 5

Long-Term Debt

 

The revolver borrowings outstanding under the Credit Facility as of August 3, 2024 included $75.1 million U.S. revolver borrowings and $2.7 million (C$3.8 million) related to GCO Canada ULC. We were in compliance with all the relevant terms and conditions of the Credit Facility and Facility Agreement as of August 3, 2024. Excess availability under the Credit Facility was $219.4 million at August 3, 2024.

 

Note 6

Earnings Per Share

Weighted-average number of shares used to calculate earnings per share are as follows:

 

 

 

Three Months Ended

 

 

Six Months Ended

 

(Shares in thousands)

 

August 3, 2024

 

 

July 29, 2023

 

 

August 3, 2024

 

 

July 29, 2023

 

Weighted-average number of shares - basic

 

 

10,942

 

 

 

11,344

 

 

 

10,936

 

 

 

11,581

 

Common stock equivalents

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Weighted-average number of shares - diluted

 

 

10,942

 

 

 

11,344

 

 

 

10,936

 

 

 

11,581

 

Common stock equivalents of 0.1 million shares and less than